029-83533393
   info@TaiBSbio.com
 
组织芯片,组织微阵列
 
RLN808肺鳞状细胞癌组织芯片,附病理分级、TNM、临床分期,80例/80点
点 数80例 数80
行 数8列 数10
点直径(mm)1.5厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.

产品名:RLN808
 
肺鳞状细胞癌组织微阵列,包含80例鳞状细胞癌,一例一点
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Lun
-Lung
 
Malignant (IA2)
 
Malignant (IB)
 
Malignant (IIA)
 
Malignant (IIB)
 
Malignant (IIIA)
 
Malignant (IIIB)
TISSUE  ARRAYS RLN808
1
2
3
4
5
6
7
8
9
10
A
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
B
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
C
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
D
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
E
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
F
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
G
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
H
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeTumor SizeisBackUp
A1160MLungSquamous cell carcinoma with necrosis1T2N1M0IIBMalignant4*3*3N
A2253MLungSquamous cell carcinoma1T2N0M0IBMalignant3*3*3N
A3330MLungSquamous cell carcinoma with necrosis1--2T2aN0M0IBMalignant4.5*4*3N
A4450MLungSquamous cell carcinoma with necrosis1--2T2N0M0IBMalignant7.5*5*4N
A5530MLungSquamous cell carcinoma with necrosis2T2N0M0IBMalignant5*3*3N
A6668MLungSquamous cell carcinoma with necrosis2T2N1M0IIBMalignant5*5*5N
A7758MLungSquamous cell carcinoma2T3N1M0IIIAMalignant4*4*3N
A8848MLungSquamous cell carcinoma2T2N1M0IIBMalignant*N
A9972MLungSquamous cell carcinoma2T2N0M0IBMalignant4*3*3N
A101052FLungSquamous cell carcinoma2T2N0M0IBMalignant*N
B11159MLungSquamous cell carcinoma with necrosis2T2N0M0IBMalignant*N
B21260FLungSquamous cell carcinoma with necrosis2T2N1M0IIBMalignant5*4*4N
B31347MLungSquamous cell carcinoma with necrosis2T2aN0M0IBMalignant*N
B41465MLungSquamous cell carcinoma with necrosis2T2aN0M0IBMalignant*N
B51557MLungSquamous cell carcinoma with necrosis2T2N0M0IBMalignant8*8*7N
B61670MLungSquamous cell carcinoma2T3N0M0IIBMalignant5*4*4N
B71763MLungSquamous cell carcinoma2T2N0M0IBMalignant3*2*1.5N
B81866MLungSquamous cell carcinoma2T2N0M0IBMalignant5*2*3.5N
B91963MLungSquamous cell carcinoma with necrosis2T2bN0M0IIAMalignant*N
B102069MLungSquamous cell carcinoma2T2N0M0IBMalignant*N
C12164MLungSquamous cell carcinoma with necrosis2T2N0M0IBMalignant5*4*4N
C22272MLungSquamous cell carcinoma with necrosis2T2N1M0IIBMalignant7*3*1.5N
C32356MLungSquamous cell carcinoma2T3N0M0IIBMalignant6.5*5*5N
C42467MLungSquamous cell carcinoma with necrosis2T2N0M0IBMalignant4*3.5*3N
C52546MLungSquamous cell carcinoma with necrosis2T3N1M0IIIAMalignant*N
C62662MLungSquamous cell carcinoma2T2N0M0IBMalignant*N
C72769MLungSquamous cell carcinoma (sparse)2T2N1M0IIBMalignant7*5*4N
C82868MLungSquamous cell carcinoma (sparse)2T3N0M0IIBMalignant6*4*3.5N
C92951MLungSquamous cell carcinoma with necrosis2T2N1M0IIBMalignant5*4*4N
C103053FLungSquamous cell carcinoma2T2N1M0IIBMalignant*N
D13162MLungSquamous cell carcinoma with necrosis2T2bN1M0IIBMalignant*N
D23259MLungSquamous cell carcinoma2T2bN0M0IIAMalignant*N
D33350MLungSquamous cell carcinoma2T2aN1M0IIBMalignant5*4*4N
D43455MLungSquamous cell carcinoma2T2bN0M0IIAMalignant5.5*4*3.5N
D53553MLungSquamous cell carcinoma with necrosis2T2aN1M0IIBMalignant*N
D63668MLungSquamous cell carcinoma with necrosis2T2N2M0IIIAMalignant*N
D73755MLungSquamous cell carcinoma2T2aN0M0IBMalignant*N
D83869MLungSquamous cell carcinoma2T2N0M0IBMalignant6*5*4N
D93967MLungSquamous cell carcinoma with necrosis2T2bN1M0IIBMalignant7*6*6N
D104054MLungSquamous cell carcinoma with necrosis2T2aN0M0IBMalignant10*9*5N
E14161MLungSquamous cell carcinoma2T2aN0M0IBMalignant*N
E24268MLungSquamous cell carcinoma (adenocarcinoma)*T2aN0M0IBMalignant*N
E34363MLungSquamous cell carcinoma with necrosis2--3T3N2M0IIIBMalignant*N
E44465MLungSquamous cell carcinoma with necrosis2--3T2aN0M0IBMalignant*N
E54566MLungSquamous cell carcinoma2--3T2aN0M0IBMalignant*N
E64653MLungSquamous cell carcinoma2--3T3N1M0IIIAMalignant16*13*9N
E74767MLungSquamous cell carcinoma with necrosis2--3T2N0M0IBMalignant3*2.5N
E84866MLungSquamous cell carcinoma2--3T2bN0M0IIAMalignant*N
E94950FLungSquamous cell carcinoma2--3T2aN0M0IBMalignant*N
E105059FLungSquamous cell carcinoma2--3T3N2M0IIIBMalignant*N
F15133MLungSquamous cell carcinoma with necrosis3T4N0M0IIIAMalignant7.5*4.5*3N
F25246FLungSquamous cell carcinoma with necrosis3T2N0M0IBMalignant*N
F35371MLungSquamous cell carcinoma3T2N0M0IBMalignant*N
F45465MLungSquamous cell carcinoma with necrosis3T2N0M0IBMalignant4*4*3N
F55562MLungSquamous cell carcinoma with necrosis3T2N0M0IBMalignant*N
F65676MLungSquamous cell carcinoma with necrosis3T2N0M0IBMalignant3*2*1N
F75768MLungSquamous cell carcinoma with necrosis3T4N1M0IIIAMalignant8*7*5N
F85863MLungSquamous cell carcinoma with necrosis3T3N1M0IIIAMalignant*N
F95952MLungSquamous cell carcinoma3T2N0M0IBMalignant3*2*2N
F106063MLungSquamous cell carcinoma3T2N0M0IBMalignant*N
G16155MLungSquamous cell carcinoma with necrosis3T2N0M0IBMalignant4*3.5*2N
G26243FLungSquamous cell carcinoma3T2aN1M0IIBMalignant*N
G36370MLungSquamous cell carcinoma with necrosis3T2aN0M0IBMalignant*N
G46471MLungSquamous cell carcinoma with necrosis3T3N0M0IIBMalignant5*4*4N
G56545FLungSquamous cell carcinoma with necrosis3T2N0M0IBMalignant5*4*2.5N
G66648MLungSquamous cell carcinoma3T2N0M0IBMalignant5*3.5*3N
G76772MLungSquamous cell carcinoma with necrosis3T2N0M0IBMalignant6*4*4N
G86856MLungSquamous cell carcinoma3T3N2M0IIIBMalignant7*6*5N
G96964MLungSquamous cell carcinoma with necrosis3T2bN3M0IIIBMalignant5.5*4.0*3.5N
G107065MLungSquamous cell carcinoma3T2N1M0IIBMalignant*N
H17156MLungSquamous cell carcinoma3T1N2M0IIIAMalignant*N
H27264FLungSquamous cell carcinoma3T2N0M0IBMalignant*N
H37363MLungSquamous cell carcinoma3T2N1M0IIBMalignant*N
H47462MLungSquamous cell carcinoma with necrosis3T2aN1M0IIBMalignant5*5*4N
H57563MLungSquamous cell carcinoma with necrosis3T2bN1M0IIBMalignant*N
H67645MLungSquamous cell carcinoma with necrosis2T2aN0M0IBMalignant5*4*4N
H77761MLungSquamous cell carcinoma3T2N0M0IBMalignant*N
H87846MLungSquamous cell carcinoma with necrosis3T2N0M0IBMalignant*N
H97954MLungSquamous cell carcinoma with necrosis3T1bN1M0IIBMalignant*N
H108071MLungSquamous cell carcinoma with necrosis3T1bN0M0IA2Malignant*N
Tissue Marker
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址:陕西西安市灞桥区长乐东路2999号
电话:029-83533393, 17792711553,
电子邮箱:taibsbio@163.com
QQ:3144647811
微信号:13002913390
邮政编码:710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售,加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队,并且具有庞大的组织标本库。样本库中组织微阵列种类多,病理类型齐全,同时根据客户需求情况进行制作加工新的组织微阵列,尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度,致力于为广大客户提供质量好的产品和优质的服务。

更多详情